Results 171 to 180 of about 89,572 (287)

Human Tamm-Horsfall protein as a novel antitumor therapy for triple negative breast cancer and other solid tumors. [PDF]

Sci Rep
Mercogliano MF, Bruni S, De Martino M, Balanian L, Castellano MA, Groisman J, Inserra F, Schillaci R, de Cavanagh EMV.   +8 more
europepmc   +1 more source

The Effect of Strength Training During Chemotherapy in Women With Breast Cancer on Serum Cytokine Concentrations and Skeletal Muscle Autophagy‐Related Proteins

European Journal of Sport Science, Volume 26, Issue 7, July 2026.
ABSTRACT To evaluate whether strength training during chemotherapy alters (1) serum cytokines and (2) skeletal muscle autophagy‐ and heat‐shock‐related proteins in women with breast cancer. Exploratory analyses assessed associations between changes in physiological outcomes (muscle strength, cardiorespiratory fitness, and capillary density) and ...
Emelie Strandberg, Olav Vikmoen, Karianne Vassbakk Svindland, Atle Wendel Scheie, Hege Nymo Ødemark, Anna Henriksson, Sveinung Berntsen, Truls Raastad   +7 more
wiley   +1 more source

Immune, molecular and genetic profiles of gastric signet ring cell carcinoma: Recent progress and future challenges

International Journal of Cancer, Volume 159, Issue 1, Page 11-29, 1 July 2026.
Abstract Gastric signet ring cell carcinoma (GSRCC) is a special type of gastric cancer common in young women. Diffuse gastric cancer (DGC) begins with intramucosal lesions comprising differentiated GSRCC cells. Genetically, GSRCC and DGC are clonally identical, with their morphology influenced by extracellular Wnt signaling.
Qian Wang, Shuai Zhou, Xiongchao Fang, Xianli He, Gang Wang, Nan Wang   +5 more
wiley   +1 more source

Efficacy of Docetaxel Plus Ramucirumab for Malignant Pleural Effusion and Cerebral Edema in Patients With Advanced Non-Small Cell Lung Cancer: A Single-Institution Retrospective Study. [PDF]

Thorac Cancer
Morita M, Wakuda K, Matsuda S, Sekikawa M, Miura K, Kodama H, Yabe M, Mamesaya N, Kobayashi H, Ko R, Ono A, Kenmotsu H, Naito T, Murakami H, Takahashi T.   +14 more
europepmc   +1 more source

Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study.

, 2008
Although the taxanes represent the most active agents for the first-line treatment of metastatic hormone-refractory prostate cancer (HRPC), most patients eventually progress while receiving taxane-based treatments.
Figg WD, Giordano A, Autorino R, Labianca R, DE PLACIDO, SABINO, MIRONE, VINCENZO, Di Lorenzo G, Fossa SD, GIULIANO, MARIO, Perdonà S, LONGO, NICOLA, IMBIMBO, CIRO   +11 more
core  

Neuroendocrine Transformation Without PSA Elevation in High‐Risk Metastatic Castration‐Sensitive Prostate Cancer Under Androgen Receptor Signaling Inhibition: A Case Report

IJU Case Reports, Volume 9, Issue 4, July 2026.
ABSTRACT Introduction Neuroendocrine prostate cancer is a rare and highly aggressive variant of prostate cancer with a poor prognosis. We report a case in which metastatic castration‐sensitive prostate cancer directly transformed into neuroendocrine prostate cancer without a corresponding increase in prostate‐specific antigen.
Yoshihiro Nakagami, Shintaro Ohnuma, Masashi Tamaoka, Tatsuki Inoue, Motoki Yamagishi, Kazuhiko Oshinomi, Masakazu Nagata, Yasuyuki Oohira, Toshiko Yamochi, Takashi Fukagai   +9 more
wiley   +1 more source

Experimental study of liposomal docetaxel analysis of docetaxel incorporation and stability

, 2017
The article presents the results of developing the composition and technology of obtaining the liposomal form of docetaxel. The effect of the phospholipid composition of the membrane, ionic strength, pH, temperature, cryoprotectant type, and other ...
Krasnopolsky, Yu. M., Dudnichenko, А. S.   +1 more
core  

Synthesis, Characterization, Antioxidant Evaluation, Cytotoxicity Studies, and Molecular Docking of Novel Sulfonamide Derivatives

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 7, July 2026.
A series of novel sulfonamide derivatives (4a–i) were synthesized and characterized. Compound 4d showed significant antioxidant activity, while compounds 4g, 4h, and 4i exhibited high cytotoxicity against ovarian and prostate cancer cells, particularly 4h with a log IC50 of 1.343 µg/mL.
Ouissal Bouraoui, Güldeniz Şekerci, Khaled Mesbah, James A. Ezugwu, Rachid Benkiniouar, Suat Tekin, Fatümetüzzehra Küçükbay, Houssem Boulebd, Hasan Küçükbay   +8 more
wiley   +1 more source

CRIP1 promotes docetaxel resistance and immune-associated cell death modulation in prostate cancer. [PDF]

Front Pharmacol
Zhang D, Han M, Yan N, Zhang Y, Wang C, Shi W, Jia W, Cao J.   +7 more
europepmc   +1 more source

Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment?

Medicinal Research Reviews, Volume 46, Issue 4, Page 1111-1151, July 2026.
ABSTRACT Prostate cancer (PCa) is the second most frequently diagnosed cancer in men worldwide and the fifth leading cause of cancer‐related mortality, presenting urgent unmet clinical needs in diagnosis and treatment. The recognition of the microbiome as a key factor in human health has prompted numerous studies, revealing an exciting new approach to ...
Lara R. S. Fonseca, Mariana Feijó, Cátia V. Vaz, Bruno J. Pereira, Sandra Laurentino, Ana Palmeira‐de‐Oliveira, Sílvia Socorro   +6 more
wiley   +1 more source